1. Genome editing by miniature CRISPR/Cas12f1 enzyme in Escherichia coli
- Author
-
Yu Sato, Kohsuke Honda, Tatsuya Hizume, and Kenji Okano
- Subjects
0106 biological sciences ,0301 basic medicine ,Streptococcus pyogenes ,Bioengineering ,medicine.disease_cause ,01 natural sciences ,Applied Microbiology and Biotechnology ,03 medical and health sciences ,Genome editing ,010608 biotechnology ,Escherichia coli ,medicine ,CRISPR ,Gene ,Gene Editing ,Genetics ,Nuclease ,biology ,Cas9 ,Protospacer adjacent motif ,030104 developmental biology ,biology.protein ,CRISPR-Cas Systems ,Biotechnology - Abstract
The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system is a valuable genome editing tool for microorganisms. However, the commonly used Cas9 nuclease derived from Streptococcus pyogenes (SpCas9) is not applicable to many industrially relevant bacteria, due to its cytotoxicity and large size (1368 amino acids [aa]). We developed an alternative genome editing system using a miniature Cas12f1 nuclease (529 aa) derived from an uncultured archaeon, Un1Cas12f1. When editing four dispensable genes in Escherichia coli MG1655 and BW25113, the CRISPR/Un1Cas12f1 system showed higher efficiency (63%-100%) than the CRISPR/SpCas9 system (50%-79%). The CRISPR/Un1Cas12f1 genome editing system is expected to be applied to the genome editing of a wide variety of bacteria.
- Published
- 2021